Goldman Sachs Future Health Care Equity ETFNYSE Arca:GDOC
- LAST PRICE32.42
- TODAY'S CHANGE (%)-1.03 (-3.07%)
- Bid / Lots29.56/ 1
- Ask / Lots---/ ---
- Open / Previous Close33.05 / 33.45
- Day Range
- 52 Week Range
- Volume773
- Overall Morningstar RatingNot Ratedout of 268 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GDOC |
|---|---|---|
| 09:32 ET | 327 | 33.05 |
| 10:24 ET | 100 | 32.7 |
| 03:57 ET | 247 | 32.4 |
| 04:00 ET | 247 | 32.4185 |
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 08/20/2024 | -0.05% |
| 08/21/2024 | -0.03% |
| 08/22/2024 | -0.14% |
| 08/23/2024 | 0.05% |
| 08/26/2024 | -0.04% |
| 08/27/2024 | -0.03% |
| 08/28/2024 | 0.05% |
| 08/29/2024 | -0.03% |
| 08/30/2024 | 0.02% |
| 09/03/2024 | -0.28% |
| 09/04/2024 | -0.25% |
| 09/05/2024 | -0.18% |
| 09/09/2024 | -0.27% |
| 09/10/2024 | -0.12% |
| 09/11/2024 | -0.08% |
| 09/12/2024 | -0.12% |
| 09/13/2024 | -0.06% |
| 09/16/2024 | 0.02% |
| 09/17/2024 | -0.17% |
| 09/18/2024 | 0.02% |
| 09/19/2024 | 0.03% |
| 09/20/2024 | 0.00% |
| 09/23/2024 | -0.03% |
| 09/24/2024 | -0.06% |
| 09/25/2024 | -0.04% |
| 09/26/2024 | -0.08% |
| 09/27/2024 | -0.08% |
| 09/30/2024 | 0.01% |
| 10/01/2024 | -0.06% |
| 10/02/2024 | 0.11% |
| 10/03/2024 | -0.11% |
| 10/04/2024 | 0.10% |
| 10/07/2024 | -0.38% |
| 10/08/2024 Largest Premium | 0.15% |
| 10/09/2024 | 0.11% |
| 10/10/2024 | -0.04% |
| 10/11/2024 | 0.03% |
| 10/14/2024 | 0.11% |
| 10/15/2024 Largest Discount | -0.40% |
| 10/16/2024 | -0.06% |
| 10/17/2024 | -0.04% |
| 10/18/2024 | 0.06% |
| 10/21/2024 | -0.12% |
| 10/22/2024 | 0.11% |
| 10/23/2024 | 0.03% |
| 10/24/2024 | 0.04% |
| 10/25/2024 | -0.16% |
| 10/28/2024 | 0.06% |
| 10/29/2024 | 0.05% |
| 10/30/2024 | -0.03% |
| 10/31/2024 | 0.10% |
| 11/01/2024 | -0.02% |
| 11/04/2024 | -0.15% |
| 11/05/2024 | 0.05% |
| 11/06/2024 | -0.16% |
| 11/08/2024 | -0.02% |
| 11/11/2024 | -0.15% |
| 11/12/2024 | -0.01% |
| 11/13/2024 | 0.02% |
| 11/14/2024 | -0.13% |
| 11/15/2024 | -0.16% |
| US Stock | 75.8% |
|---|---|
| Non-US Stock | 22.5% |
| Cash | 1.7% |
| Convertible | 0 |
| Non-US Bond | 0 |
| Other | 0 |
| Healthcare | 98.3% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 77.1% |
|---|---|
| Asia/Oceania | 6.1% |
| Europe | 0.6% |
| Canada | 0.5% |
| Africa | 0 |
| Latin America | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 11.3% | 0.00% | $2.5M |
Boston Scientific Corp | Long | 6.9% | 0.00% | $1.5M |
AstraZeneca PLC | Long | 6.0% | 0.00% | $1.3M |
Intuitive Surgical Inc | Long | 5.5% | 0.00% | $1.2M |
AbbVie Inc | Long | 5.4% | 0.00% | $1.2M |
Novo Nordisk AS Class B | Long | 5.4% | 0.00% | $1.2M |
Amgen Inc | Long | 4.6% | 0.00% | $1.0M |
Insulet Corp | Long | 4.3% | 0.00% | $937.5K |
The Cooper Companies Inc | Long | 3.9% | 0.00% | $856.8K |
Abbott Laboratories | Long | 3.9% | 0.00% | $852.2K |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | MSCI ACWI/Health Care NR USD |
|---|---|
Category | |
Sponsor | Goldman Sachs Asset Management, L.P. |
Inception | November 9, 2021 |
The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.
| Total Net Assets | $22.1M |
|---|---|
| Shares Out. | 650.0K |
| Net Asset Value (NAV) | $32.47 |
| Prem/Discount to NAV | -0.16% |
| P/E Ratio | 37.1 |
| Dividend Yield | 0.55% |
| Dividend per Share | 0.18 USD |
| Ex-Dividend Date | 12/26/2023 |
| Dividend Payment Date | 01/2/2024 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Large Cap Growth |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.75% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.75% |